ARIMIDEX Offers Women Greater Protection Against HR+ Early Breast Cancer Returning In
"Anastrozole is the only aromatase inhibitor (AI) which has now been shown to prevent recurrences in women with hormone receptor positive early breast cancer both during the initial high-risk two years after surgery, and also well beyond the completion of treatment.
Linear Mode
